After Prostate Surgery

Prostate Cancer Support News

Does Dayton really need two proton therapy centers?Wednesday, September 8, 2010 @ 10:35AMThe two separate projects--which still exist only on the drawing board at this point--would make Dayton the nation's only area to house two proton therapy centers, and have prompted questions about whether the area really needs, or can handle, both of the pricey and humongous facilities. There are currently just seven operating proton therapy centers in the U.S., though many more are in the ...

Help in facing a killer inside youWednesday, September 8, 2010 @ 10:05AMA diagnosis of prostate cancer can be crushing but you don't have to face it alone, writes Malcolm Brown.

Mushroom Festival: What's new this year?Wednesday, September 8, 2010 @ 9:46AMIt's become a delightful habit in Southern Chester County: the annual return of the Mushroom Festival in Kennett Square.

Classic cars for a causeWednesday, September 8, 2010 @ 9:20AMClassic car lovers better be all revved up and ready to go for the 19th annual Cruisin’ by the Bay Car Show, which takes place Sept. 9-12 on the streets of downtown Sandusky. This year’s suped-up event features over 400 cars from classic antiques to hot rods, with more than 25 awards in 20 classes. By date (default) read more

Quick links:Wednesday, September 8, 2010 @ 8:43AMCommunityLinks... A listing of local community groups and events.

Clubs and meetings in Tewksbury, the Clintons, High Bridge, Readington, Califon, Bethlehem and High BridgeWednesday, September 8, 2010 @ 8:12AMThe Senior Citizens Of Bethlehem Township meet the first Monday of each month at 12:30 p.m. in the Municipal Building, 405 Mine Road. Membership is based on attaining the age of 55 years. Those eligible are urged to join for the fun and fellowship. For additional information, phone 735-8023.

Positive results from YM BioSciences' CYT997 Phase I study for vascular disruption in tumorsWednesday, September 8, 2010 @ 7:22AMYM BioSciences Inc., today announced the publication of Phase I results demonstrating that CYT997, a novel vascular disrupting agent (VDA), was well tolerated at doses that were associated with pharmacodynamic evidence of vascular disruption in tumors. The article entitled "Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent," was published in the premier cancer journal, the ...

Cylene to Report Recent Advances With First-in-Class CK2 Inhibitor, CX-4945, at International CK2 ConferenceWednesday, September 8, 2010 @ 7:00AMCylene Pharmaceuticals, Inc. will report recent developments with its first-in-class, oral CK2 inhibitor CX-4945, at the 6th International Conference on Protein Kinase CK2, to be held on September 7-10 in Cologne, Germany, the company announced today.

PHEN Leads Request To President Obama To Light The White House Blue In Support of the Fight Against Prostate CancerWednesday, September 1, 2010 @ 7:52PMBoston, MA (BlackNews.com) -- The Prostate Health Education Network, Inc. (PHEN) is leading an effort of prostate cancer advocacy organizations requesting that President Obama "light the White House blue and hang a blue ribbon" during the week of September 13th in recognition of September as "Prostate Cancer Awareness Month."